Santhera Pharmaceuticals Holding AG
SANN
Classement en actions
#16590
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Prix de l'action
$17.23
Capitalisation boursière
$263.68M
Changement (1 jour)
-4.18%
Changement (1 an)
38.54%
Pays
CH
Échange Santhera Pharmaceuticals Holding AG (SANN)
Catégorie
Healthcare
Historique du prix de l'action pour Santhera Pharmaceuticals Holding AG (SANN)
Prix de clôture le plus élevé : $18.92 le 2026-10-01
Prix de clôture le plus bas : $44.13 le 2014-03-01
Prix de clôture le plus bas : $44.13 le 2014-03-01
Historique du prix de l'action de Santhera Pharmaceuticals Holding AG de 2014 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | 22.24% |
| 2025 | 42.98% |
| 2024 | -6.16% |
| 2023 | 41.12% |
| 2022 | -43.82% |
| 2021 | -53.14% |
| 2020 | -74.39% |
| 2019 | -17.31% |
| 2018 | -49.89% |
| 2017 | -38.99% |
| 2016 | -48.52% |
| 2015 | -16.32% |
| 2014 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
